ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2021
Serum Micro-RNA-122 Level as a Simple Noninvasive Marker of MAFLD Severity.
Mona A Hegazy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it